Parcion Private Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$581K Sell
2,572
-37
-1% -$7.85K 0.03% 268
2026
Q2
$564K Buy
2,609
+469
+22% +$89.7K 0.03% 244
2026
Q1
$392K Buy
2,140
+44
+2% +$8.11K 0.02% 290
2025
Q4
$369K Buy
2,096
+477
+29% +$77.9K 0.02% 287
2025
Q3
$227K Buy
+1,619
New +$219K 0.01% 324
2025
Q2
– Sell
-1,724
Closed -$236K – 302
2025
Q1
$236K Buy
+1,724
New +$246K 0.02% 250

Other funds holding BIIB

Parcion Private Wealth's BIIB Position: Q3 2026 in Review

Parcion Private Wealth reduced its Biogen (BIIB) stake by 1.4% in Q3 2026, selling an estimated $7.85K and leaving 2,572 shares worth $581K. The position accounts for 0.03% of the portfolio, ranked #268.

Parcion Private Wealth first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 461 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Parcion Private Wealth held 2,572 shares of Biogen worth $581K as of Q3 2026.
  • Parcion Private Wealth sold 37 Biogen shares in Q3 2026, an estimated $7.85K.
  • Biogen made up 0.03% of Parcion Private Wealth's portfolio in Q3 2026, its #268 holding.
  • Parcion Private Wealth first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
  • 461 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Parcion Private Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.